Home>>Signaling Pathways>> Neuroscience>> Monoamine Oxidase>>Desmethoxyyangonin (Demethoxyyangonin)

Desmethoxyyangonin (Demethoxyyangonin) (Synonyms: Demethoxyyangonin, NSC 68686, NSC 112161, trans-5,6-Dehydrokavain)

Catalog No.GC30392

Desmethoxyyangonin (Demethoxyyangonin) is one of the six major kavalactones found in the Piper methysticum (kava) plant; reversible inhibitor of MAO-B.

Products are for research use only. Not for human use. We do not sell to patients.

Desmethoxyyangonin (Demethoxyyangonin) Chemical Structure

Cas No.: 15345-89-8

Size Price Stock Qty
5 mg
$153.00
In stock
10 mg
$259.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Desmethoxyyangonin is one of the six major kavalactones found in the Piper methysticum (kava) plant; reversible inhibitor of MAO-B.

[1]. Uebelhack R, et al. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry. 1998 Sep;31(5):187-92. [2]. Baum SS, et al. Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats. Prog Neuropsychopharmacol Biol Psychiatry. 1998 Oct;22(7):1105-20. [3]. Ma Y, et al. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23. Drug Metab Dispos. 2004 Nov;32(11):1317-24.

Reviews

Review for Desmethoxyyangonin (Demethoxyyangonin)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Desmethoxyyangonin (Demethoxyyangonin)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.